1. Miyake, Akira, Takahashi, Shinji, Nakamura, Yukihiro, Mochizuki, Shinobu, Katou, Masao. . Disruption of the ether-a-go-go K+ channel gene BEC1/KCNH3 enhances cognitive function. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 29, 14637-45. doi:10.1523/JNEUROSCI.0901-09.2009. https://pubmed.ncbi.nlm.nih.gov/19923296/
2. Li, Zhongjun, Huang, Lishan, Wei, Li, Wen, Chuangyu, Huang, Suran. 2020. KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer. In OncoTargets and therapy, 13, 10323-10333. doi:10.2147/OTT.S268055. https://pubmed.ncbi.nlm.nih.gov/33116612/
3. Weiss, Simone, Lamy, Philippe, Rusan, Maria, Borre, Michael, Sørensen, Karina Dalsgaard. 2024. Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies. In International journal of cancer, 155, 298-313. doi:10.1002/ijc.34949. https://pubmed.ncbi.nlm.nih.gov/38602058/
4. Vezzali, Riccardo, Weise, Stefan Christopher, Hellbach, Nicole, Heidrich, Stefanie, Vogel, Tanja. . The FOXG1/FOXO/SMAD network balances proliferation and differentiation of cortical progenitors and activates Kcnh3 expression in mature neurons. In Oncotarget, 7, 37436-37455. doi:10.18632/oncotarget.9545. https://pubmed.ncbi.nlm.nih.gov/27224923/
5. Pan, Jianbo, Liu, Sheng, Farkas, Michael, Qian, Jiang, Al Kahtani, Eman. 2016. Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes. In Molecular vision, 22, 636-45. doi:. https://pubmed.ncbi.nlm.nih.gov/27307695/